Ulpiano Flores, a business analyst with Converge Consulting, speaks about Phase 3 companies navigating DSCSA serialization requirements in an interview with Tracelink.
Subscribe to our mailing list for the latest insights on advanced therapy development, regulatory updates, industry trends, and upcoming events from Dark Horse Consulting Group.
We respect your privacy. Unsubscribe at any time. We will never sell your information.